Marta Ribasés is an expert in Psychiatry at Vall d'Hebron Hospital Universitari (Spain). As of September 2026, ScienceLeadR ranks Marta Ribasés in the top 1% of experts worldwide for Attention Deficit Disorder with Hyperactivity. Marta Ribasés has authored 241 publications, the most recent in 2026. SLR score: 727 (community average: 125). How the SLR is computed.

LeadR Profile

727 ScienceLeadR Reputation 727
Network Map

Psychiatry

Subspecialties: Genetics - Pharmacy - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2003 - 2026

Source: PubMed

Vall d'Hebron Hospital Universitari

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 241

Citations

Citations: 23 183 1st author: 15 Last author: 46 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Genome-wide analysis of social behaviour across social domains, reporters and developmental stages: a meta-regression approach.
PMID 42768150 — genome, mental health
Nat Hum Behav20260
Genome-wide association analyses of borderline personality disorder identify 11 loci and highlight shared risk with mental and somatic disorders.
PMID 42477112 — genes, personality disorders, borderline personality disorder, personality, genome, stress disorders, traumatic, wounds and injuries
Nat Genet20261
Genetic overlap between depression and C-reactive protein levels: Evidence from a cross-trait analysis.
PMID 42320223 — depression, genes, body mass index, c-reactive protein
Eur Neuropsychopharmacol20260
Towards disentangling the polygenic contribution of dyslexia to school performance.
PMID 42173846 — psychopathology, language, dyslexia, schools, aged, mathematics, child, genetic load, psychiatry
Transl Psychiatry20260
Common and rare variant contributions to discontinuation of stimulant treatment in ADHD.
PMID 41764167 — genome, adolescent, therapeutics, child, psychiatry, attention deficit disorder with hyperactivity
Transl Psychiatry20260

LeadR Networks

Main global connection map